Skip to content

Supplier News

Valeant to buy Bausch+Lomb for $8.7 billion

Valeant Pharmaceuticals International Inc. is acquiring Bausch+Lomb Holdings Inc. for $8.7 billion in cash. With the deal, announced on Monday, Bausch+Lomb will retain its name and become a division of Valeant.

Longtime Forest Labs CEO plans to retire

Howard Solomon is slated to retire as president and chief executive officer of Forest Laboratories Inc. at the end of this year. Forest Labs said Thursday that Solomon will step down as president and CEO on Dec. 31. He is expected to remain as chairman through the 2014 annual general meeting, at

Perrigo’s stock to move to NYSE

Perrigo Co. is transferring its U.S. common stock listing to the New York Stock Exchange (NYSE) from the Nasdaq Global Select Market. The company said Thursday that it expects to start trading on the NYSE on June 6 under its current stock symbol, "PRGO.

Elite Pharmaceuticals COO to step down

Chris Dick, president and chief operating officer at Elite Pharmaceuticals Inc., plans to leave those posts and the company’s board of directors later this month. Elite said Tuesday that the change will become effective on May 24.

Kellogg appoints U.S. sales president

Darcey Macken has been promoted to president of U.S. sales at Kellogg Co. Macken, currently senior vice president of customer development for U.S. sales, will succeed Mark Wagner, who plans to retire from Kellogg on Dec. 31 after more than 30 years of service at the company. Soon Darcey will meet

CoverGirl sponsors ‘Hunger Games’ sequel

CoverGirl has announced its first-ever movie sponsorship, for Lionsgate’s "The Hunger Games: Catching Fire" due out this fall. The Procter & Gamble cosmetics brand said that for the film, scheduled for release in North American theaters on Nov.

Instaflex Joint Support now carried by Walgreens

Instaflex Joint Support nutritional supplements have hit store shelves at Walgreens locations nationwide. Direct Digital LLC, developer and marketer of the brand, said Thursday that the store distribution expands its retail presence with Walgreens.

Mylan releases Zomig generic

Mylan Inc. has received final approval from the Food and Drug Administration for zolmitriptan tablets, a treatment for migraine headaches. The company said Wednesday that its zolmitriptan product, which has begun shipping, comes in dosages of 2.